This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Innovations in Polycystic Disease Treatment by Sergio A. Gradilone
Introduction
Sergio A. Gradilone, an inventive researcher based in Rochester, MN, has made significant contributions to the medical field, particularly in the treatment of polycystic diseases. With two patents to his name, Gradilone's work focuses on advanced therapeutic strategies that target complex pathological conditions.
Latest Patents
Gradilone's latest patents revolve around the use of an HDAC6-specific inhibitor to combat polycystic diseases. The research demonstrates that this specific inhibitor can effectively reduce the pathogenesis associated with polycystic diseases. Notably, the administration of the HDAC6-specific inhibitor has been shown to alleviate numerous symptoms inherent to polycystic liver disease, including cyst formation, cyst growth, and cholangiocyte proliferation. Moreover, treatment not only increases the levels of acetylated tubulin and β-catenin phosphorylation but also effectively reduces bile duct β-catenin synthesis. These findings underscore the overexpression of HDAC6 in cystic cholangiocytes and the potential of its pharmacological inhibition to mitigate both cholangiocyte proliferation and cyst growth.
Career Highlights
Gradilone is associated with the United States of America as represented by the Secretary of the Department of Health and Human Services. Throughout his career, he has focused on translational research aimed at addressing challenges in liver diseases, enhancing therapeutic avenues for affected individuals.
Collaborations
Sergio A. Gradilone collaborates closely with his coworker, Nicholas F. LaRusso. Their partnership reflects a commitment to advancing research that interlinks various aspects of hepatology and therapeutic development.
Conclusion
Sergio A. Gradilone stands out as an innovative inventor dedicated to improving treatments for polycystic diseases. His patents reveal a promising approach to addressing complex medical challenges, illustrating the importance of continued research and innovation in the field of health sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile